Cargando...
Recombinant Peptides as Biomarkers for Tumor Response to Molecular Targeted Therapy
PURPOSE: Phage display technology can be used to identify peptide sequences which bind rapidly and specifically to tumors responding to sunitinib therapy. These peptides may help to address problems with current methods of assessing tumor response to therapy which can be slow and have limited usage....
Gardado en:
Main Authors: | , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado: |
2009
|
Assuntos: | |
Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2763341/ https://ncbi.nlm.nih.gov/pubmed/19825959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-0945 |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|